

BioMark Diagnostics Announces Landmark Publication Validating High Specificity and Accuracy of its Early-Stage Lung Cancer Test
Study Published in a special issue of International Journal of Molecular Sciences Confirms Test’s Ability
The latest information about BioMark Diagnostics to keep you up to date.
BioMark Diagnostics is leading the world in early-stage cancer detection with an oncology focus designed to improve patient outcomes.
Study Published in a special issue of International Journal of Molecular Sciences Confirms Test’s Ability
Milestone strengthens transparency and credibility as the Company advances commercialization of its metabolomics technology platform
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. BioMark
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. BioMark
Personal Reflection: A Shared Journey of Loss and Hope My journey with BioMark Diagnostics is
BioMark Diagnostics Underscores Commitment to Rare Disease Research on Rare Disease Day 2025 BioMark is
From Black Plastics to Biomarkers How Environmental Causes of Cancer Can Be Prevented Seemingly harmless
Cancer is Rising Among Young Women: Early Detection of Lung Cancer Lung cancer rates are
Cancer Prevention: 5 Actionable Steps Take control of your health and reduce your cancer risk
No paperwork, no hassle. We keep things digital, easy and regular.
*Zero Spam Policy. You will need to confirm your email address to receive our news to your inbox.
1 604 370 0779
130 3851 Shell Road
Richmond BC
Canada V6X 2W2
Rashid A. Bux (CEO)
[email protected]